Prolactin: a new therapeutic target in peripartum cardiomyopathy
Bultmann I, Hilfiker-Kleiner D, Sliwa K, Yamac H(March 1, 2010)
Summary: Yamac H, Bultmann I, Sliwa K, Hilfiker-Kleiner D. Prolactin: a new therapeutic target in peripartum cardiomyopathy. Heart 2010; 96(17): 1352-1357.
Categories: 2010, Peer Reviewed Articles
Ethanolamine is a novel STAT-3 dependent cardioprotective agent
Hacking D, Kelly RF, Lacerda L, Lamont KT, Lecour S, Opie LH, Somers S, Thomas P(March 1, 2010)
Summary: Kelly RF, Lamont KT, Somers S, Hacking D, Lacerda L, Thomas P, Opie LH, Lecour S. Ethanolamine is a novel STAT-3 dependent cardioprotective agent. Basic Res Cardiol 2010; 105(6): 763-770.
Categories: 2010, Peer Reviewed Articles
TNFα protects cardiac mitochondria independently of its cell surface receptors
Lacerda L, Lecour S, Lynn EG, McCarthy J, Mungly SF, Opie LH, Sack MN(March 1, 2010)
Summary: Lacerda L, McCarthy J, Mungly SF, Lynn EG, Sack MN, Opie LH, Lecour S. TNFα protects cardiac mitochondria independently of its cell surface receptors. Basic Res Cardiol 2010; 105(6): 751-762.
Categories: 2010, Peer Reviewed Articles
Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study
Ball J, Carrington MJ, Klug E, Lee G, Opie L, Sliwa K, Stewart S(March 1, 2010)
Summary: Sliwa K, Carrington MJ, Klug E, Opie L, Lee G, Ball J, Stewart S. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study. Heart 2010; 96(23): 1878-1882.
Categories: 2010, Peer Reviewed Articles
Mutation-specific risk in two genetic forms of type 3 long QT syndrome
Ackerman MJ, Benhorin J, Crotti L, Goldenberg I, Jons C, Liu JF, McNitt S, Moss AJ, Qi M, Robinson JL, Schwartz PJ, Spazzolini C, Zareba W(March 1, 2010)
Summary: Liu JF, Moss AJ, Jons C, Benhorin J, Schwartz PJ, Spazzolini C, Crotti L, Ackerman MJ, McNitt S, Robinson JL, Qi M, Goldenberg I, Zareba W: Mutation-specific risk in two genetic forms of type 3 long QT syndrome. Am J Cardiol 2010; 105: 210-213
Categories: 2010, Peer Reviewed Articles
On behalf of the Sections of Sports Cardiology of the European Association of Cardiovascular Prevention and Rehabilitation; and the Working Group of Myocardial and Pericardial Disease of the European Society of Cardiology
Anastasakis A, Basso C, Biffi A, Bjørnstad HH, Borjesson M, Buja G, Carrè F, Corrado D, Delig iannis A, Delise P, Drezner J, Dugmore D, Estes NA 3rd, Fagard R, Gussac I, Heidbuchel H, Hoogsteen J, Iliceto S, Link M, Maron BJ, McKenna WJ, Mellwig KP, Panhuyzen-Goedkoop N, Peidro R, Pelliccia A, Schwartz PJ, Sharma S, Solberg E, Stein R, Thiene G, Vanhees L, Zeppilli P(March 1, 2010)
Summary: Corrado D, Pelliccia A, Heidbuchel H, Sharma S, Link M, Basso C, Biffi A, Buja G, Delise P, Gussac I, Anastasakis A, Borjesson M, Bjørnstad HH, Carrè F, Delig iannis A, Dugmore D, Fagard R, Hoogsteen J, Mellwig KP, Panhuyzen-Goedkoop N, Solberg E, Vanhees L, Drezner J, Estes NA 3rd, Iliceto S, Maron BJ, Peidro R, Schwartz PJ, Stein R, Thiene G, Zeppilli P, McKenna WJ; On behalf of the Sections of Sports Cardiology of the European Association of Cardiovascular Prevention and Rehabilitation; and the Working Group of Myocardial and Pericardial Disease of the European Society of Cardiology: Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J Eur Heart J 2010; 31: 243-259.
Categories: 2010, Peer Reviewed Articles
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy
Buchmann E, Elkayam U, Hilfker-Kleiner D, McMurray JV, Mebazaa A, Mouquet F, Pankuweit S, Papp Z, Petrie MC, Pieske B, Regitz-Zagrosek V, Schaufelberger M, Seferovic PM, Shah AJ, Sliwa K, Tavazzi L, vanVeldhuisen DJ, Watkins H(February 27, 2010)
Summary: Sliwa K, Hilfker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, vanVeldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JV. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. European Journal of Heart Failure 2010; 12: 767-778.
Categories: 2010, Peer Reviewed Articles
The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT dyspnoea study
Andre S, Cleland JG, Collins SP, Filippatos G, Frank Peacock W, Gayat E, Gheorghiade M, Hasa J, Laribi S, Mark Courtney D, Masip J, Mebazaa A, Pang PS, Sliwa K, Spinar J, Storrow AB, Tavares M(November 30, -0001)
Summary: Mebazaa A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S, Andre S, Mark Courtney D, Hasa J, Spinar J, Masip J, Frank Peacock W, Sliwa K, Gayat E, Filippatos G, Cleland JG, Gheorghiade M. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT dyspnoea study. Eur Heart J. 2010; 31(7): 832-841.
Categories: 2010, Peer Reviewed Articles
Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports
Drexler H, Hilfiker-Kleiner D, Labidi S, Meyer GP, Podewski E, Sliwa K(November 30, -0001)
Summary: Meyer GP, Labidi S, Podewski E, Sliwa K, Drexler H, Hilfiker-Kleiner D. Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports. J Med Case Reports 2010; March 4; 4: 80.
Categories: 2010, Peer Reviewed Articles
AMPK activation represses the human gene promoter of the cardiac isoform of acetyl-CoA carboxylase: Role of nuclear respiratory factor-1
Adam T, Essop MF, Opie LH(November 30, -0001)
Summary: Adam T, Opie LH, Essop MF. AMPK activation represses the human gene promoter of the cardiac isoform of acetyl-CoA carboxylase: Role of nuclear respiratory factor-1. Biochem Biophys Res Commun., 2010, 398(3): 495-499.
Categories: 2010, Peer Reviewed Articles
Download
